Intellia Therapeutics Inc (NTLA)
Stock-Based Compensation
$141.95M
TTM · Period ending: · USD
NTLA Stock-Based Compensation
Latest reported$141.95Mperiod ending
Latest reported$141.95Mperiod ending
NTLA TTM Stock-Based Comp ($1.31M → $141.95M)
TTM stock-based compensation
High-resolution chart · PNG
NTLA stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 141,951,000 | |
| 145,912,000 | |
| 154,273,000 | |
| 103,097,000 | |
| 123,112,000 | |
| 141,937,000 | |
| 154,273,000 | |
| 149,699,000 | |
| 145,432,000 | |
| 140,971,000 | |
| 134,050,000 | |
| 123,633,000 | |
| 113,496,000 | |
| 100,164,000 | |
| 91,400,000 | |
| 81,335,000 | |
| 71,530,000 | |
| 59,076,000 | |
| 47,009,000 | |
| 38,030,000 | |
| 28,020,000 | |
| 22,170,000 | |
| 19,903,000 | |
| 17,337,000 | |
| 15,016,000 | |
| 14,656,000 | |
| 15,091,000 | |
| 15,657,000 | |
| 17,034,000 | |
| 17,531,000 | |
| 17,046,000 | |
| 20,060,000 | |
| 18,851,000 | |
| 16,799,000 | |
| 15,322,000 | |
| 10,741,000 | |
| 9,549,000 | |
| 8,533,000 | |
| 6,715,000 | |
| 5,163,000 | |
| 3,687,000 | |
| 2,005,000 | |
| 1,308,000 | |
| 1,115,000 | |
| 536,000 |